15 Percent of Pregnant Women With COVID-19 Experience Severe Disease
Nearly all of those with severe disease in case series were overweight or obese before pregnancy
Convalescent Plasma Appears Promising for Severe COVID-19
In series of 25 patients, 19 experienced improvement in clinical status by day 14; 11 were discharged
Experimental COVID-19 Vaccine Appears Safe, Triggers Immune Response
Findings from early-stage trial that started in March and included eight healthy people receiving two doses
Most Physicians Have Seen False-Negative COVID-19 Test Results
One in 10 physicians worldwide report seeing at least one case of COVID-19 reinfection
Hydroxychloroquine No Aid for COVID-Related Mortality
Hydroxychloroquine alone or with azithromycin associated with abnormal electrocardiogram findings
Cough May Not Appear in Young Children With COVID-19
Digestive tract infection appears common in children hospitalized with COVID-19 in China
Interferon-α2b May Shorten Viral Shedding Duration in COVID-19
Duration of elevated blood levels for inflammatory markers IL-6, C-reactive protein also reduced
ACP Advises Against Chloroquine, Hydroxychloroquine for COVID-19
Practice points based on lack of evidence supporting use as prophylaxis or treatment for COVID-19
NIH: Large-Scale Testing of Some COVID-19 Vaccines Could Start in July
About a dozen potential vaccines worldwide are in the initial stages of, or set to begin, testing in people
NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID-19
Trial will enroll 2,000 patients with SARS-COV-2 who have fever, cough, and/or shortness of breath
